IL-37 also significantly inhibited the release of TNF-α, IL-1β, and IL-6 in peripheral blood mononuclear cells (PBMCs) of patients with systemic lupus erythematosus (SLE) in vitro36. Here, IL37 is linked to systemic lupus erythematosus.